Tag: Hormones: Male
Harmonized Normal Range of Testosterone Established
In non-obese European and American men, aged 19 to 39 years, normal range is 264 to 916 ng/dL
Increased VTE Risk for Men Starting Testosterone Therapy
Risk peaks in the first six months of hormone treatment, but overall odds are low
ADT Use Not Linked to Dementia in Prostate Cancer
No increased risk of dementia for androgen deprivation therapy use versus nonuse
Small Increase in Hematocrit With Implantable Testosterone
Statistically significant 2.2 percent increase in mean hematocrit unlikely to be clinically relevant
FDA Warns of Testosterone, AAS Abuse and Dependence
Many American men take them, but heart and psychological issues can occur, agency says
Continued 2 Percent Daily Testosterone Safe, Effective
Also found to improve sex drive and energy in men with androgen deficiency
Androgen Deprivation Therapy May Raise Dementia Risk
Men on ADT found to have twice the risk of developing dementia within five years of treatment
Testosterone Seems Safe for Hypogonadal Prostate CA Patients
Testosterone therapy seems oncologically safe after treatment or for those on active surveillance
Testosterone Solution Found Safe, Effective for Hypogonadal Men
Once-daily 2 percent testosterone solution safe and effective for sex drive and energy
Testosterone Gel Improves Sexual Function in Older Men
Gel hormone treatment led to improved libido, increased sexual activity
